Eukedos SpA
MIL:EUK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (12.9), the stock would be worth €0.49 (23% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16.7 | €0.64 |
0%
|
| 3-Year Average | 12.9 | €0.49 |
-23%
|
| 5-Year Average | 17.2 | €0.65 |
+3%
|
| Industry Average | 12.6 | €0.48 |
-25%
|
| Country Average | 11.1 | €0.42 |
-34%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
|
Eukedos SpA
MIL:EUK
|
14.4m EUR | 16.7 | -12.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
100.2B USD | 14.1 | 56.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.5B EUR | 10.5 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.9B EUR | 12.4 | 18.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.9B USD | 14.2 | 22.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 16 | 24.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 6.5 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | -64.9 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 10.5 | 14.2 |
Market Distribution
| Min | 0.7 |
| 30th Percentile | 7 |
| Median | 11.1 |
| 70th Percentile | 14.7 |
| Max | 4 040.2 |
Other Multiples
Eukedos SpA
Glance View
Eukedos SpA specializes in the managed care and nursing home management sectors. The company is headquartered in Florence, Firenze and currently employs 799 full-time employees. The company went IPO on 2006-08-01. The company operates through four segments. The Care segment is focused on the management of retirement homes for elderly and adults disabled. The Medical Devices segment covers production and supply of products for infusion therapy and non-woven products to other customized products for the pharmaceutical industry. The Equipment segment includes the design, manufacturing and supply of machines for washing and sterilization for the pharmaceutical and hospital equipment, as well as cooking machines for the communities. The Contract segment covers the manufacturing and supplying turnkey furniture for hospitals, nursing homes, and communities in general. On June 2013, it sold a 70% stake in Teoreo Srl to Piofin Srl. In August 2013, it sold a 66.07% stake in San Nicola Srl for its subsidiary Edos SpA. In October 2013, it sold a 100% stake of its subsidiary Icos Impianti Group.
